List of products supplied under the Plasma Products Agreement
Supplier |
Product type/trade name |
Clinical use approved under the National Blood Arrangements |
CSL Limited |
Albumin |
|
|
Albumex® 4 |
Used to treat hypovolaemia arising from shock, surgery or multiple organ failure |
|
Albumex® 20 |
Used to treat patients suffering extensive burns or shock due to blood loss, or kidney or liver disease |
|
Immunoglobulins |
|
|
Hyperimmune globulins |
Used to prevent a specific infection such as tetanus, hepatitis B, Zoster or cytomegalovirus |
|
Intragam® P |
Used to reduce susceptibility to infections and manage many immune system disorders |
|
Clotting factors |
|
|
Biostate® |
Used to treat Factor VIII deficiency, known as haemophilia A |
|
MonoFIX®-VF |
Used to treat patients who have Factor IX deficiency, known as haemophilia B or Christmas disease |
|
Prothrombinex®-VF |
Used to manage some bleeding disorders (concentrated clotting factors) and warfarin reversal |
|
Thrombotrol®-VF |
Used to manage an inherited condition wherein a patient’s blood clots too quickly |
List of imported rare bleeding and blood disorder plasma products
Supplier |
Product type/trade name |
Clinical use approved under the National Blood Arrangements |
Baxter Healthcare Pty Ltd |
Anti Inhibitor Coagulant Complex Concentrates/FEIBA® |
Used to treat bleeding episodes including surgical interventions in haemophilia A and B patients with inhibitors |
Baxter Healthcare Pty Ltd |
Protein C/Ceprotin® |
Used to treat congenital Protein C deficiency |
Baxter Healthcare Pty Ltd |
FVII concentrate |
Used to treat Factor VII deficiency |
Baxter Healthcare Pty Ltd |
WinRho |
Used to prevent a potentially fatal form of anaemia in newborn babies of Rh (D) negative mothers |
CSL Limited |
FXI/BPL Factor XI |
Used to treat people with Factor XI deficiency (sometimes called haemophilia C) |
CSL Limited |
FXIII/Fibrogammin® P |
Used to treat people with Factor XIII deficiency |
CSL Limited |
Rh (D) Immunoglobulin/WinRho® |
Used to prevent haemolytic disease of the newborn (HDNB), a potentially fatal form of anaemia in newborn babies of Rh (D) negative mothers |
List of imported rare bleeding and blood disorder recombinant products
Supplier |
Product type/trade name |
Clinical use approved under the National Blood Arrangements |
Novo Nordisk Pharmaceuticals Pty Ltd |
rFVIIa/NovoSeven® |
Used to treat bleeding episodes including surgical intervention in haemophilia A or B patients with inhibitors to Factor VIII or Factor IX; also used to treat complex bleeding episodes in surgery, trauma and septicaemia |
Baxter Healthcare Pty Ltd |
rFVIII/Recombinate® |
Used to treat Factor VIII deficiency, known as haemophilia A |
Baxter Healthcare Pty Ltd |
rFVIII/Advate® |
Used to treat Factor VIII deficiency, known as haemophilia A |
Wyeth Australia Pty Ltd |
rFVIII/Refacto® |
Used to treat Factor VIII deficiency, known as haemophilia A |
Wyeth Australia Pty Ltd |
rFIX/BeneFIX® |
Used to treat patients who have Factor IX deficiency, known as haemophilia B or Christmas disease |